Merck is currently trading at Rs. 642.00, up by 9.40 points or 1.49% from its previous closing of Rs. 632.60 on the BSE.
The scrip opened at Rs. 639.00 and has touched a high and low of Rs. 642.00 and Rs. 631.00 respectively. So far 831 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 699.00 on 10-Sep-2012 and a 52 week low of Rs. 530.00 on 09-Apr-2013.
Last one week high and low of the scrip stood at Rs. 660.00 and Rs. 628.60 respectively. The current market cap of the company is Rs. 1050.74 crore.
The promoters holding in the company stood at 51.80% while Institutions and Non-Institutions held 22.13% and 26.06% respectively.
Merck, a manufacturer of ingredients for cosmetics industry has entered into partnership pact with French firm Greenpharma SAS to market latter’s cosmetic ingredient ‘poppy seed extract’. As per the agreement, Merck will market the active ingredient globally under its umbrella brand RonaCare, as of September 2013.
Additionally, Merck will be liable for sales, logistics and application technology customer support. Poppy seed extract is a skin-firming substance with a dual mechanism of action.
Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.50 |
| Dr. Reddys Lab | 1233.20 |
| Cipla | 1232.00 |
| Zydus Lifesciences | 937.70 |
| Lupin | 2327.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: